The epigenome consists of a system of chemical tags that attach to our DNA and its associated molecules, switching genes on and off. But the system is not without glitches—and scientists think that the misplacement of these tags can cause disease. This idea has led to new drugs that aim to correct gene activity (and obliterate disease) by altering the proteins around which DNA winds. Cassandra Willyard examines whether this approach will unlock the long-awaited promise of epigenetic therapy.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Willyard, C. The saving switch. Nat Med 16, 18–21 (2010). https://doi.org/10.1038/nm0110-18
Issue Date:
DOI: https://doi.org/10.1038/nm0110-18
- Springer Nature America, Inc.
This article is cited by
-
Epigenetic modulation of the renal β-adrenergic–WNK4 pathway in salt-sensitive hypertension
Nature Medicine (2011)
-
Epigenetik in der Rheumatologie
Zeitschrift für Rheumatologie (2011)